SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-047417
Filing Date
2019-08-26
Accepted
2019-08-26 16:52:09
Documents
2
Period of Report
2019-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5105
2 POA DOCUMENT poa.txt EX-24.4_870232 3492
  Complete submission text file 0001209191-19-047417.txt   9963
Mailing Address ALLOS THERAPEUTICS, INC. 11080 CIRCLEPOINT ROAD, SUITE 200 WESTMINSTER CO 80020
Business Address
EDWARDS MARK G (Reporting) CIK: 0001190429 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 191053467

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations